
ProFound Therapeutics: Innovating impactful disease understanding and therapeutic creation.
ProFound Therapeutics, a pioneering company founded under the Flagship Pioneering umbrella, is dedicated to creating profound impacts on the understanding of biology and disease. The company's core mission is to expand the human proteome beyond traditional boundaries, revealing new possibilities for therapeutic development. ProFound Therapeutics focuses on leveraging advanced scientific insights to innovate and develop novel medicines, aiming to transform the landscape of disease treatment and patient care.
Notable figures affiliated with ProFound Therapeutics include leading scientists and industry experts from Flagship Pioneering. The company has achieved significant milestones in expanding the known human proteome, which has the potential to revolutionize drug discovery and development. By illuminating previously unknown aspects of human biology, ProFound Therapeutics is making a substantial impact on the biotechnology and pharmaceutical industries, paving the way for groundbreaking therapies and improved health outcomes.

Vesalius Therapeutics
vesaliustx.com

Ampersand Biomedicines
ampersand.bio

Alltrna
alltrna.com

Empirico
empiricotx.com

Nested Therapeutics
nestedtx.com

Paratus Sciences

Deep Apple Therapeutics
deepappletx.com

Frontier Medicines
frontiermeds.com

Adcentrx Therapeutics
adcentrx.com

Initial Therapeutics
initialtx.com

Differentiated Therapeutics
dxtherapeutics.com

Provenance Biopharmaceuticals
provenancebio.com

Variant Bio
variantbio.com

Oviva Therapeutics
ovivatx.com

Juvena Therapeutics

Enavate Sciences

Proterris
proterris.com
Triplet Therapeutics
triplettx.com

Secretome Therapeutics

Petri Bio
petribio.com
ProFound Therapeutics' most recent funding round was for $75M (USD) in May 2022.
As of May 27, 2022, ProFound Therapeutics has disclosed funding of $75M (USD).